Gufic BioSciences' Stock Surges 15.84% in 3 Days, Outperforming Sector
Gufic BioSciences, a smallcap pharmaceutical company, has seen a surge in its stock price, gaining 7.01% on August 22, 2024 and hitting a new 52-week and all-time high. The company's strong financial performance and growth prospects in the pharmaceutical industry have caught the attention of investors and analysts, making it a stock to watch out for.
Gufic BioSciences, a smallcap pharmaceutical company, has been making headlines in the stock market with its recent surge in stock price. On August 22, 2024, the company's stock gained 7.01%, outperforming the sector by 7.16%. This marks the third consecutive day of gains for Gufic BioSciences, with a total increase of 15.84% in the past three days.
The stock hit a new 52-week and all-time high of Rs. 398 on the same day, showing a strong upward trend. This has caught the attention of investors and analysts, with MarketsMOJO giving a 'Hold' call for the stock.
Gufic BioSciences has also been performing well in comparison to the broader market, with a 1-day performance of 6.36% compared to Sensex's 0.18% and a 1-month performance of 14.25% compared to Sensex's 0.69%.
The company's stock is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. This can be attributed to the company's strong financial performance and growth prospects in the pharmaceutical industry.
Gufic BioSciences has been consistently delivering good results and has a strong product portfolio in various therapeutic areas. With its recent surge in stock price, the company is gaining attention from investors and analysts, making it a stock to watch out for in the pharma sector.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
